Preview
Description
The myHizentra™ App has been developed by CSL Behring (Australia) Pty Ltd. ABN 48 160 734 761 (“CSL Behring”), 189–209 Camp Rd, Broadmeadows VIC 3047, Australia. This app is designed to be used only by Australian patients prescribed HIZENTRA®. An activation code is therefore required to access the app. Australian patients can contact their nurse or doctor to request an activation code. The app includes information about HIZENTRA and a patient diary to record HIZENTRA infusions. In the diary, patients can also track their symptoms and both the symptoms and infusion history can be exported to send to a patients nurse or doctor. The app also includes an infusion reminder service and barcode scanner functionality so patient can easily record and manage their HIZENTRA stock in the home.
What's New
Version 3.0.4 2025-04-02
· Fixes a bug that may prevent some iOS users from recording infusions. Technical Analysis
Package Overview Basic metadata
Bundle ID
au.com.csl.myhizentra Current Version 3.0.4
Minimum iOS 15.6
Package Size App Store Size
Package Metadata 1 / 1 version records
Detailed binary, privacy manifest, framework, and Info.plist results have not been indexed for this package yet. The verified App Store and archive metadata above remains available.
Developer Information
Known Version Records
1 version record with stored package metadata
Stored metadata does not guarantee a package is currently available to download.
| Details | Version / IDs | Version date | Action |
|---|---|---|---|
 12.47 MB | v3.0.3 App Store ID: 864575443Build: 10 | 2024-03-18 11:36:08 | Get Version |